Actively Recruiting
Looking for a Blood Epigenetic Signature to Predict Female Infertility
Led by Università Vita-Salute San Raffaele · Updated on 2023-10-24
1456
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.
CONDITIONS
Official Title
Looking for a Blood Epigenetic Signature to Predict Female Infertility
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Woman aged over 18 and under 43 years
- Infertile woman undergoing assisted reproductive technology (ART)
- History of recurrent pregnancy loss
You will not qualify if you...
- Age under 18 years or over 44 years
- Previous ovarian surgery
- Severe male factor infertility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Università Vita Salute San Raffaele
Milan, Italy
Actively Recruiting
Research Team
V
Valeria Stella Vanni
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here